vs
康美（CNMD）与CapsoVision, Inc（CV）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是CapsoVision, Inc的105.5倍（$373.2M vs $3.5M）。康美自由现金流更多（$41.2M vs $-5.7M）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
CapsoVision, Inc.是一家医疗科技企业，专注研发、生产先进胶囊内窥镜系统及配套诊断解决方案，旗下非侵入式胃肠道成像产品供应全球多地的医院、消化科诊所及医疗专业人员，助力提升消化道疾病检测准确率与患者诊疗体验。
CNMD vs CV — 直观对比
营收规模更大
CNMD
是对方的105.5倍
$3.5M
自由现金流更多
CNMD
多$46.9M
$-5.7M
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $3.5M |
| 净利润 | — | $-7.9M |
| 毛利率 | 58.5% | 54.1% |
| 营业利润率 | 9.8% | -226.7% |
| 净利率 | — | -223.9% |
| 营收同比 | 7.9% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.54 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDCV
| Q4 25 | $373.2M | — | ||
| Q3 25 | $337.9M | $3.5M | ||
| Q2 25 | $342.3M | $3.3M | ||
| Q1 25 | $321.3M | — | ||
| Q4 24 | $345.9M | — | ||
| Q3 24 | $316.7M | — | ||
| Q2 24 | $332.1M | — | ||
| Q1 24 | $312.3M | — |
净利润CNMDCV
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | $-7.9M | ||
| Q2 25 | $21.4M | $-4.6M | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $49.0M | — | ||
| Q2 24 | $30.0M | — | ||
| Q1 24 | $19.7M | — |
毛利率CNMDCV
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | 54.1% | ||
| Q2 25 | 55.0% | 54.6% | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 56.5% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 55.1% | — |
营业利润率CNMDCV
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | -226.7% | ||
| Q2 25 | 11.1% | -140.3% | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | 11.2% | — |
净利率CNMDCV
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | -223.9% | ||
| Q2 25 | 6.3% | -139.5% | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.5% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | 6.3% | — |
每股收益（稀释后）CNMDCV
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | $-0.17 | ||
| Q2 25 | $0.69 | $-2.02 | ||
| Q1 25 | $0.19 | — | ||
| Q4 24 | $1.09 | — | ||
| Q3 24 | $1.57 | — | ||
| Q2 24 | $0.96 | — | ||
| Q1 24 | $0.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | $20.4M |
| 总资产 | $2.3B | $25.7M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
总债务CNMDCV
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — | ||
| Q1 24 | $990.1M | — |
股东权益CNMDCV
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $20.4M | ||
| Q2 25 | $1.0B | $-139.0M | ||
| Q1 25 | $977.6M | — | ||
| Q4 24 | $962.7M | — | ||
| Q3 24 | $932.9M | — | ||
| Q2 24 | $881.8M | — | ||
| Q1 24 | $854.7M | — |
总资产CNMDCV
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $25.7M | ||
| Q2 25 | $2.3B | $9.5M | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.3B | — |
负债/权益比CNMDCV
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $41.2M | $-5.7M |
| 自由现金流率自由现金流/营收 | 11.0% | -160.5% |
| 资本支出强度资本支出/营收 | 1.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $150.9M | — |
8季度趋势，按日历期对齐
经营现金流CNMDCV
| Q4 25 | $46.3M | — | ||
| Q3 25 | $53.7M | $-5.7M | ||
| Q2 25 | $29.1M | $-9.5M | ||
| Q1 25 | $41.5M | — | ||
| Q4 24 | $43.3M | — | ||
| Q3 24 | $51.2M | — | ||
| Q2 24 | $43.3M | — | ||
| Q1 24 | $29.1M | — |
自由现金流CNMDCV
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | $-5.7M | ||
| Q2 25 | $23.4M | $-9.6M | ||
| Q1 25 | $37.8M | — | ||
| Q4 24 | $39.3M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | $27.1M | — |
自由现金流率CNMDCV
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | -160.5% | ||
| Q2 25 | 6.8% | -289.0% | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.7% | — |
资本支出强度CNMDCV
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | 0.3% | ||
| Q2 25 | 1.7% | 2.1% | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率CNMDCV
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
CV
暂无分部数据
